PA-BOOMI
9.4.2024 15:01:34 CEST | Business Wire | Press release
Boomi™, the intelligent integration and automation leader, is thrilled to announce Boomi World is back. The company’s highly anticipated industry event will take place May 6-9, 2024 at the Sheraton Denver Downtown Hotel in Denver, Colorado. Boomi World 2024 promises to be a transformative experience, bringing together industry leaders, technology experts, and visionary professionals to explore the latest trends and innovations in AI, integration, and automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240409873041/en/
Boomi World 2024 User Conference to Feature Deion “Coach Prime” Sanders (Graphic: Business Wire)
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2024 will feature esteemed guest speakers, including:
- Collegiate Head Football Coach and Pro Football Hall of Famer Deion Sanders
- Tropicana CIO Jeff Lischett
- Australian Red Cross CIO Brett Wilson
- Fever-Tree Head of Technology Kate Stables
- KORE Wireless Senior Director of Enterprise Applications Nicki Brock
- OSI Digital CMO Karen Dosanjh
- Gartner Senior Director Analyst John Santoro
- BARC US CEO Shawn Rogers
- IDC Research Director/Analyst Shari Lava
- Boomi CEO Steve Lucas
- Boomi Chief Product and Technology Officer Ed Macosky
- Boomi CTO Matt McLarty; and more!
Boomi World 2024 will provide attendees the opportunity to experience the power of AI-driven connection. Boomi’s customers and partners will discover how Boomi’s intelligent integration and automation platform helps organizations tame IT complexity, drive radical innovation, and synchronize everything, everywhere.
Event Highlights:
1. Robust Agenda
Boomi World 2024 boasts a dynamic and comprehensive agenda, featuring thought-provoking sessions, hands-on workshops, and engaging panel discussions. Attendees will have the opportunity to dive into the latest advancements in integration technology, best practices, and success stories from forward-thinking enterprises across industries that have transformed their organizations with Boomi.
2. Special Guest Deion Sanders
Boomi welcomes Deion Sanders, aka “Coach Prime,” as its special guest speaker.
As head coach from 2020-2022, Sanders led Jackson State University (JSU) to back-to-back SWAC Championships, and won back-to-back SWAC Coach of the Year honors. During his time at JSU, the Tigers had a 27-6 record, including a perfect regular season in 2022. In 2021, he was named the Eddie Robinson Coach of the Year.
Sanders is a member of the Pro Football Hall of Fame, a two-time Super Bowl champion, and eight-time Pro Bowler. He played 14 years in the NFL for the Atlanta Falcons, San Francisco 49ers, Dallas Cowboys, Washington Commanders, and Baltimore Ravens. Sanders is the only person in professional sports history to play in both the World Series and the Super Bowl.
After retiring from professional sports, Sanders became an analyst for CBS Sports and NFL Network, and now offers his insights and opinions on the Pro Football Show on Barstool Sports. He has produced and/or appeared in a variety of television shows, including Tiny House Nation, Grandfathered, Moesha, Running Wild With Bear Grylls, Lip Sync Battle, The League, 30 For 30: Deion’s Double Play, Deion’s Family Playbook, and, most recently, Coach Prime, a docuseries on Prime Video which follows Sanders and his college football journey.
3. Exclusive Announcements
Be the first to hear Boomi's latest product and platform updates, roadmap, and strategic initiatives. Boomi World 2024 will feature exclusive announcements that will shape the future of AI, integration, and automation.
4. Pre-Conference Training and Partner Summit
Starting on May 6, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various Platform Services within the Boomi platform, including Integration, runtime architecture, API Management, and Master Data Hub.
Taking place on May 7, the Boomi Partner Summit provides partners an exclusive look at the future of the Boomi ecosystem. Partners will get a sneak peek at upcoming announcements and gain access to go-to-market resources designed to drive growth while helping customers more quickly and easily connect, automate, and modernize their digital landscape.
5. 40+ Breakout Sessions
Boomi World will offer more than 40 breakout sessions focused on the following four tracks:
Hands-On Labs will offer attendees the opportunity to explore what’s new in the Boomi platform, get creative with AI, and learn about Retrieval-Augmented Generation — including how to set up a RAG using Boomi.
Developer/Technical track, which will include sessions on popular integration use cases, runtime monitoring, error-handling strategies, master data management, and “Boomi on Boomi” solutions.
CIO/Executive track for executive attendees — or anyone interested in topics designed to appeal to CIOs — which will feature sessions on risk management, Boomi platform security, and AI readiness.
Innovation track, which will include a wide range of sessions from customers, partners, industry analysts, and Boomi technology experts designed to showcase the myriad ways the Boomi platform can be used to connect and transform organizations.
6. Networking Opportunities
Connect with like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2024 provides a unique platform to foster collaboration, share ideas, and build valuable relationships within the integration, automation, and connectivity community.
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2024 possible, including Cognizant and Infosys as Diamond sponsors, and Apica, Kitepipe, LTIMindtree, R Systems, TCS, and United Techno as Platinum sponsors.
Registration:
Registration is now open. Secure your spot at Boomi World 2024 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Learn more about the Boomi platform
- Follow Boomi on LinkedIn, X (Twitter), Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409873041/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom